fast-tracked drug development in just 37 weeks

A rapid and robust IND-enabling package

Learn how Evotec’s INDiGO solution allowed a small US biotech to rapidly and efficiently achieve regulatory submission of their key asset in just 37 weeks.

Key points in our case study:

  • A robust regulatory data package was delivered ahead of schedule and within budget
  • Evotec’s integrated approach ensured rapid decision-making and careful risk management
  • Thanks to the application of the team’s scientific knowledge and regulatory awareness, the asset was quickly approved and entered clinical development

How can you ensure a rapid and robust IND-enabling package that minimizes risk and delivers results in the shortest possible timeframe?

View our video and download our case study!

Evotec INDiGO Case Study - HEP C